University of California-San Francisco · NeuroscienceBoxer Neurodegeneration Lab
Adam L. Boxer · San Francisco, California
Research Focus
Dr. Adam L. Boxer leads a research lab focusing on Progressive Supranuclear Palsy (PSP), a fatal neurodegenerative disease with no effective treatments. His lab aims to evaluate the safety and efficacy of multiple new therapies in PSP patients through efficient clinical trials that can expedite access to promising treatments. Using advanced diagnostic tools and collaborative platforms, the lab seeks to develop new biomarkers and therapeutic strategies to improve patient outcomes.
Progressive Supranuclear Palsyclinical trialstau proteinbiomarkersneurodegenerative diseasestherapeutic developmentbrain healthPSP Rating Scaledrug efficacy
Research Aims
5AIM 01Evaluate the efficacy of multiple therapies for PSP in a single clinical trial.
AIM 02Identify biomarkers associated with PSP progression.
AIM 03Increase patient access to experimental treatments through efficient trial designs.
AIM 04Develop new diagnostic tools for PSP based on trial findings.
AIM 05Create a collaborative research infrastructure to support PSP studies.
Skills the Lab Values
clinical trial designparticipant recruitmentMRI diagnosticsplacebo-controlled studiesdata managementbiomarker analysissafety assessmentsstatistical analysismedical imagingpatient care coordination
Output against the department
Publications604top 8% of dept.57th of 671
this lab
most publishedleast published
Citations38ktop 9% of dept.59th of 671
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.